Scientific Adviser, National Institute for Health and Care Excellence (NICE)
Sophie Cooper is currently a Scientific Adviser in the Science Policy and Research programme at NICE, following several years’ experience in NICE's Technology Appraisals programme. Her role involves developing Institute responses to science policy issues and undertaking and commissioning...
Read More →LL
Associate Director Technology Appraisals (Cancer Drugs Fund), National Institute for Health and Care Excellence (NICE)
IL
Health Outcomes Manager, Communications, Policy and Access Directorate, F. Hoffmann-La Roche
SP
Professor, University of York
Chair ESMO Patient Advocates Working Group (PAWG), Melanoma Patients
Bettina Ryll, MD/PhD founded the Melanoma Patient Network Europe in 2013 and developed a special interest in patient-centric clinical research and drug development. Bettina’s current areas of focus are Adaptive Licensing/ MAPPS , innovative sustainable healthcare models and patient-centered...
Read More →
Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA, Norwegian Medicines Agency (NoMA), Norway
Anja Schiel has studied Biology at the Johannes Gutenberg-University, Mainz, Germany. She received her PhD from the Free University in Amsterdam in 2006 and worked several years as Post-Doc before starting at the Norwegian Medicines Agency (NoMA) in 2012. At NoMA she is working as...
Read More →